EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Multi-omics data integration for topology-based pathway activation assessment and personalized drug ranking

Nicolas Borisov, Yaroslav Ilnytsky, Boseon Byeon, Olga Kovalchuk, Igor Kovalchuk

Molecular Omics · 2025

DOI: 10.1039/d5mo00151j ↗

At a glance

Journal article in Molecular Omics, 2025. Written by Nicolas Borisov and 4 co-authors. Institution: Armenian Bioinformatics Institute, 7 Ezras Hasratyan str., 0014, Yerevan, Armenia. Nicolas.borissoff@abi.am. Major MEDLINE topics: Computational Biology. Cited 1 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Although multi-omics analysis is popular for revealing diverse physiological effects and biomarkers in many branches of state-of-the-art molecular and cell biology and bioinformatics, there is still no consensus on a gold standard protocol for the integration of various multi-omics profiles into a uniformly shaped system bioinformatics platform. In the current study, we performed the integration of data on DNA methylation, and the expression of coding RNA (mRNA), micro-RNA (miRNA), and long non-coding RNA into a joint platform for calculation of signaling pathway impact analysis (SPIA) and drug efficiency index (DEI). We found that the mirrored and balanced DEI values fitted the DNA methylome data better than the original DEI. Additionally, the protein-coding mRNA-based values correlated more strongly with antisense lncRNA-based values than with miRNA-based values. The whole correlation between the mRNA-based and antisense lncRNA-based values was generally positive. This platform allowed integrative analysis of several levels of gene expression regulation of protein-coding genes and their regulators, including methylation and noncoding RNAs.

Subjects

MeSH terms (MEDLINE)

Computational BiologyDNA MethylationHumansRNA, Long NoncodingMicroRNAsRNA, MessengerSignal TransductionPrecision MedicineGene Expression RegulationGene Expression ProfilingMultiomics

Substances

RNA, Long NoncodingMicroRNAsRNA, Messenger

Authors and institutions

  • Armenian Bioinformatics Institute, 7 Ezras Hasratyan str., 0014, Yerevan, Armenia. Nicolas.borissoff@abi.am.
  • Vivan Therapeutics, (My Personal Therapeutics Ltd.), The Westworks, White City Place 195 Wood Lane, London, W12 7FQ, England, UK. nikolay@mypersonaltherapeutics.com.
  • Department of Biological Sciences, University of Lethbridge, Lethbridge, Alberta, T1K 3M4, Canada. igor.kovalchuk@uleth.ca.
  • Pathway Rx., 2 Fortress Rise SW, Alberta, T3H 4Z2, Canada.
  • Biomedical and Health Informatics, Computer Science Department, State University of New York, 2 S Clinton St, Syracuse, NY 13202, USA.

Cite

APA

Borisov, N., Ilnytsky, Y., Byeon, B., Kovalchuk, O., & Kovalchuk, I. (2025). Multi-omics data integration for topology-based pathway activation assessment and personalized drug ranking. Molecular Omics. https://doi.org/10.1039/d5mo00151j

Vancouver

Borisov N, Ilnytsky Y, Byeon B, Kovalchuk O, Kovalchuk I. Multi-omics data integration for topology-based pathway activation assessment and personalized drug ranking. Molecular Omics. 2025. doi:10.1039/d5mo00151j

BibTeX
@article{Borisov2025,
  author = {Borisov, Nicolas and Ilnytsky, Yaroslav and Byeon, Boseon and Kovalchuk, Olga and Kovalchuk, Igor},
  title = {Multi-omics data integration for topology-based pathway activation assessment and personalized drug ranking},
  journal = {Molecular Omics},
  year = {2025},
  doi = {10.1039/d5mo00151j}
}
Start for free →